Q4 2019 Holdings
Filed 2020-02-14 | 76 holdings | $549.7M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Adapthealth Corp(AHCO) | COM CL A | 00653Q102 | $188.9M | 17,199,888 | 34.4% |
| Centene Corp del(CNC) | COM | 15135B101 | $69.7M | 1,108,400 | 12.7% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $52.6M | 7,004,253 | 9.6% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $52.5M | 7,223,419 | 9.6% |
| Arvinas Inc(ARVN) | COM | 04335A105 | $44.7M | 1,088,234 | 8.1% |
| Alector Inc(ALEC) | COM | 014442107 | $35.8M | 2,076,812 | 6.5% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $29.5M | 184,000 | 5.4% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $22.8M | 1,628,504 | 4.1% |
| Biocryst Pharmaceuticals(BCRX) | COM | 09058V103 | $22.0M | 6,375,143 | 4.0% |
| Addus Homecare Corp(ADUS) | COM | 006739106 | $19.2M | 197,915 | 3.5% |
| Atricure Inc(ATRC) | COM | 04963C209 | $9.5M | 292,777 | 1.7% |
| Horizon Pharma Invt LTD | NOTE 2.500% 3/1 | 44052TAB7 | $191.5K | $144,832,000 | 0.0% |
| Horizon Therapeutics PUB LTD | SHS | G46188101 | $171.7K | 4,742,311 | 0.0% |
| Mylan N V | SHS EURO | N59465109 | $163.9K | 8,151,754 | 0.0% |
| Nevro Corp | NOTE 1.750% 6/0 | 64157FAA1 | $154.3K | $115,776,000 | 0.0% |
| Orchard Therapeutics PLC | ADS | 68570P101 | $121.9K | 8,862,247 | 0.0% |
| Homology Medicines Inc | COM | 438083107 | $108.6K | 5,245,638 | 0.0% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $98.5K | 4,289,291 | 0.0% |
| Mirum Pharmaceuticals Inc(MIRM) | COM | 604749101 | $84.6K | 3,448,912 | 0.0% |
| Tandem Diabetes Care Inc(TNDM) | COM NEW | 875372203 | $81.2K | 1,361,345 | 0.0% |
| Acceleron Pharma Inc(XLRN) | COM | 00434H108 | $72.6K | 1,369,625 | 0.0% |
| RA Pharmaceuticals Inc | COM | 74933V108 | $71.3K | 1,519,718 | 0.0% |
| Intersect ENT Inc | COM | 46071F103 | $69.6K | 2,797,033 | 0.0% |
| Intercept Pharmaceuticals in | NOTE 3.250% 7/0 | 45845PAA6 | $58.3K | $57,791,000 | 0.0% |
| Myokardia Inc | COM | 62857M105 | $57.5K | 789,000 | 0.0% |
| Silk Road Medical Inc | COM | 82710M100 | $51.7K | 1,279,480 | 0.0% |
| DBV Technologies S A | SPONSORED ADR | 23306J101 | $50.9K | 4,756,000 | 0.0% |
| Dexcom Inc | NOTE 0.750%12/0 | 252131AH0 | $50.4K | 34,000,000 | 0.0% |
| Rocket Pharmaceuticals Inc(RCKT) | COM | 77313F106 | $49.3K | 2,164,471 | 0.0% |
| Vericel Corp(VCEL) | COM | 92346J108 | $47.8K | 2,747,563 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $45.3K | 564,914 | 0.0% |
| Clovis Oncology Inc | NOTE 2.500% 9/1 | 189464AB6 | $42.9K | $49,064,000 | 0.0% |
| Aerie Pharmaceuticals Inc(AERIEUR) | COM | 00771V108 | $42.8K | 1,772,255 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $39.2K | 2,002,605 | 0.0% |
| Sientra Inc | COM | 82621J105 | $37.8K | 4,227,680 | 0.0% |
| Immunomedics Inc(IMMU) | COM | 452907108 | $36.5K | 1,722,618 | 0.0% |
| Editas Medicine Inc(EDIT) | COM | 28106W103 | $34.3K | 1,158,841 | 0.0% |
| Springworks Therapeutics Inc | COM | 85205L107 | $30.3K | 788,243 | 0.0% |
| Humana Inc(HUM) | COM | 444859102 | $30.1K | 82,000 | 0.0% |
| Audentes Therapeutics Inc(BOLDEUR) | COM | 05070R104 | $29.6K | 493,901 | 0.0% |
| PTC Therapeutics Inc | NOTE 3.000% 8/1 | 69366JAB7 | $28.4K | $24,877,000 | 0.0% |
| Sarepta Therapeutics Inc(SRPT) | COM | 803607100 | $27.1K | 210,000 | 0.0% |
| Constellation Pharmceticls I(CNST) | COM | 210373106 | $25.9K | 550,000 | 0.0% |
| Frequency Therapeutics Inc | COM | 35803L108 | $24.9K | 1,418,665 | 0.0% |
| Avrobio Inc | COM | 05455M100 | $23.5K | 1,164,970 | 0.0% |
| Axonics Modulation Tech Inc(AXNX*) | COM | 05465P101 | $23.2K | 837,945 | 0.0% |
| Turning Point Therapeutics I | COM | 90041T108 | $22.8K | 366,000 | 0.0% |
| Mirati Therapeutics Inc(MRTXEUR) | COM | 60468T105 | $22.4K | 174,000 | 0.0% |
| Reata Pharmaceuticals Inc(RETAEUR) | CL A | 75615P103 | $20.4K | 100,000 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $20.1K | 148,433 | 0.0% |